Cargando...

SA-4-1BBL/MPL as a novel immune adjuvant platform to combat cancer

Practical experience with cancer vaccines combined with accumulated knowledge of the complex interactions between cancer and immune system rationalize the combinatorial use of immune adjuvants for better efficacy. We recently described a novel adjuvant system based on the costimulatory SA-4-1BBL and...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncoimmunology
Main Authors: Srivastava, Abhishek K., Yolcu, Esma S., Dinc, Gunes, Sharma, Rajesh K., Shirwan, Haval
Formato: Artigo
Idioma:Inglês
Publicado: Taylor & Francis 2015
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4760279/
https://ncbi.nlm.nih.gov/pubmed/26942082
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1064580
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!